https://www.marketsandmarkets.com/MarketsandMarkets XML Feed en-us Copyright MarketsandMarkets 12/22/2025 7:36:31 PM GMT 12/22/2025 7:36:31 PM GMT 300 https://www.marketsandmarkets.com/ MarketsandMarkets – Market Research Company publishes about 120 business market researchreports a year across 10 main industries. Market research reports and industry trends analysis available from MarketsandMarkets.12/22/2025 7:36:31 PM GMT https://www.marketsandmarkets.com/Market-Reports/human-microbiome-manufacturing-services-market-255565161.htmlThe global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services....12/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/north-america-human-microbiome-market-268083046.htmlThe North America human microbiome market is expected to grow from USD 0.78 billion in 2025 to USD 4.15 billion in 2031, at a compound annual growth rate (CAGR) of 32.2% during the forecast period. The Key Players Seres Therapeutics (US), Seed Health, Inc. (US), International Flavors & Fragrances Inc. (US), Pendulum (US), Biohm Technologies (US), Resbiotic (US), Infinant Health Inc. (US), and ExeGi Pharma (US). ...12/16/2025 GMT https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.htmlThe global pharmaceutical filtration market, valued at US$13.41 billion in 2024, stood at US$14.35 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2024 to 2030, culminating in a forecasted valuation of US$21.75 billion by the end of the period....12/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.htmlThe global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period....12/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/patient-derived-xenograft-model-market-121598251.htmlThe global patient derived xenografts/PDX models market, valued at US$0.32 billion in 2024, stood at US$0.37 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation of US$0.66 billion by the end of the period. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response....11/21/2025 GMT https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.htmlThe global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics....11/20/2025 GMT https://www.marketsandmarkets.com/Market-Reports/preimplantation-genetic-testing-market-605.htmlThe global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period....11/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-free-protein-synthesis-market-141393235.htmlThe global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems....10/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/molecular-cytogenetic-market-148469224.htmlThe global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing....10/13/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.htmlThe global single-use bioprocessing market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector....10/9/2025 GMT https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.htmlThe global 3D cell culture market, valued at US$1.18 billion in 2024, stood at US$1.29 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2030, culminating in a forecasted valuation of US$2.26 billion by the end of the period. The market growth is driven by the adoption of personalized medicine globally for multiple diseases and government support & funding for 3D cell culture....10/6/2025 GMT https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.htmlThe global neuromodulation market, valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to advance at a resilient CAGR of 9.4% from 2025 to 2030, culminating in a forecasted valuation of US$10.68 billion by the end of the period. Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life. ...9/15/2025 GMT https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.htmlThe global immunohistochemistry market, valued at US$3.31 billion in 2024, stood at US$3.55 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$5.14 billion by the end of the period. The increasing number of cancer cases is one of the key factors driving the uptake of IHC products, which, in turn, leads to a greater need for accurate and efficient diagnostic tools such as IHC tests. ...9/15/2025 GMT https://www.marketsandmarkets.com/Market-Reports/ligase-enzymes-market-257141225.htmlThe global ligase enzymes market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.36 billion by the end of the period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering....9/12/2025 GMT https://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.htmlThe global human microbiome market, valued at US$0.91 billion in 2024, stood at US$1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field....8/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-cell-sequencing-market-244864213.htmlThe global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms....7/31/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biobanking-devices-market-594.htmlThe global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage....7/25/2025 GMT https://www.marketsandmarkets.com/Market-Reports/tangential-flow-filtration-market-72081607.htmlThe global tangential flow filtration market, valued at US$1.76 billion in 2024, stood at US$1.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.20 billion by the end of the period. Several factors contribute to the growth of the tangential flow filtration market, including the increasing adoption of single-use technologies and the rising demand for scalable & high-throughput purification systems in biologics manufacturing....7/22/2025 GMT https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.htmlThe global epigenetics market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 11.3% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period....7/16/2025 GMT https://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.htmlThe global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering....7/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.htmlThe global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine....7/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.htmlThe global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market....7/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biotechnology-ccontract-manufacturing-market-163964739.htmlThe global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth....7/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/in-situ-hybridization-market-212028829.htmlThe global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions....6/23/2025 GMT https://www.marketsandmarkets.com/Market-Reports/residual-dna-testing-market-89689614.htmlThe global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.37 billion by the end of the period. The growth of the Asia Pacific residual DNA testing market is primarily due to increasing number of fundings and investments by pharmaceutical and biotechnology companies for the advancement of the healthcare sector. Additionally, emerging markets in the Asia Pacific is set to enhance the residual DNA testing market growth....6/19/2025 GMT https://www.marketsandmarkets.com/Market-Reports/exosome-research-product-market-224782498.htmlThe global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region....6/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.htmlThe global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology....6/3/2025 GMT https://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.htmlThe global biomarkers market, valued at US$58.07 billion in 2024, stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine....5/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.htmlGlobal human leukocyte antigen (HLA) typing for transplant market valued at $1.0B in 2024, reached $1.1B in 2025, and is projected to grow at a robust 6.0% CAGR, hitting $1.4B by 2030. Market growth is driven by an increasing number of transplant procedures worldwide, a shift towards molecular assay technologies for HLA typing, favorable public-private investments and funding for research, and a strong focus by manufacturers on launching high-resolution HLA typing products....5/22/2025 GMT https://www.marketsandmarkets.com/Market-Reports/crispr-technology-market-134401204.htmlThe global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years....5/13/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.htmlThe global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector....5/7/2025 GMT https://www.marketsandmarkets.com/Market-Reports/collagen-gelatin-regenerative-medicine-market-95663122.htmlThe global collagen & gelatin market, valued at US$1203.9M in 2024, is forecasted to grow at a 5.8% CAGR, reaching US$1,295.5M by 2025 and US$1,671.3M by 2030. Globally, US is the largest market for collagen and gelatin and this trend is expected to continue during the forecast period...4/29/2025 GMT https://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.htmlThe global live cell imaging market, valued at US$2.88 billion in 2024, stood at US$3.13 billion in 2025 and is projected to advance at a resilient CAGR of 8.68% from 2025 to 2030, culminating in a forecasted valuation of US$4.75 billion by the end of the period. Growth in this market is primarily driven by the increasing adoption of high-content screening techniques in drug discovery, the rising incidence of cancer, and the availability of funds for research....4/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/humanized-mouse-model-market-131763955.htmlThe global humanized mouse and rat model market, valued at US$255.8M in 2024, is forecasted to grow at a 8.2% CAGR, reaching US$276.2M by 2025 and US$409.8M by 2030. The surge in the use of humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth. ...4/22/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.htmlThe global cell-based assays market, valued at US$17.36B in 2024, is forecasted to grow at a 9.1% CAGR, reaching US$18.134B by 2025 and US$25.77B by 2030. Growth in this market is primarily driven by the increasing demand for drug discovery and development, the increasing preference for cell-based assays in drug discovery, and the rising prevalence of cancer....4/21/2025 GMT https://www.marketsandmarkets.com/Market-Reports/immune-repertoire-sequencing-market-151469626.htmlGlobal immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region....4/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.htmlGlobal high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine....4/1/2025 GMT https://www.marketsandmarkets.com/Market-Reports/analytical-standards-market-8484789.htmlThe global analytical standards market, valued at US$1.44 billion in 2022, stood at US$1.53 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$2.16 billion by the end of the period. The key factors driving the market growth include the stringent regulatory guidelines in the pharmaceutical industry; increasing public-private investments for research projects; the rising public concerns about food safety & quality; and the growing applications of analytical techniques in proteomics and metabolomics....3/27/2025 GMT https://www.marketsandmarkets.com/Market-Reports/gene-therapy-market-122857962.htmlThe global gene therapy market, valued at US$7.21 billion in 2023, stood at US$8.85 billion in 2024 and is projected to advance at a resilient CAGR of 19.4% from 2025 to 2032, culminating in a forecasted valuation of US$36.55 billion by the end of the period. Market growth is attributed to factors such as the growing demand for curative therapies for genetic disorders, rare diseases, and specific types of cancer, robust clinical trial pipeline for gene therapy and increasing investments in gene therapy research. ...2/19/2025 GMT https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.htmlThe global proteomics market, valued at US$32.98 billion in 2023, stood at US$33.64 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2029, culminating in a forecasted valuation of US$60.36 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification....2/18/2025 GMT https://www.marketsandmarkets.com/Market-Reports/microcarrier-market-139831731.htmlThe global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production....2/13/2025 GMT https://www.marketsandmarkets.com/Market-Reports/cell-counting-market-157450728.htmlThe global Cell Counting Market, valued at US$10.82 billion in 2023, grew to US$11.12 billion in 2024 and is projected to reach US$11.83 billion in 2025. The market is expected to advance at a robust CAGR of 7.7% from 2024 to 2029, reaching an estimated US$16.14 billion by 2029. Increasing awareness and adoption of automated and fluorescence-based cell counters, along with declining costs, are driving broader market penetration across research laboratories, clinical diagnostics, and biopharmaceutical applications....2/11/2025 GMT https://www.marketsandmarkets.com/Market-Reports/peptide-synthesis-market-158927365.htmlThe global peptide synthesis market, valued at US$0.78 billion in 2023, stood at US$0.81 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1.41 billion by the end of the period. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders....2/4/2025 GMT https://www.marketsandmarkets.com/Market-Reports/mrna-synthesis-manufacturing-market-105705347.htmlThe global mRNA synthesis & manufacturing market, valued at US$2.22 billion in 2023, stood at US$2.23 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.96 billion by the end of the period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA synthesis technology, increased outsourcing for mRNA synthesis and modification, and collaborations among industry players....1/31/2025 GMT https://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.htmlThe global next-generation sequencing market, valued at US$12.13 billion in 2023, stood at US$12.65 billion in 2024 and is projected to advance at a resilient CAGR of 13.2% from 2024 to 2029, culminating in a forecasted valuation of US$23.55 billion by the end of the period. The primary growth drivers of the next-generation sequencing market are the surge in the rising demand for precision medicine in identifying genetic mutations and biomarkers, enabling targeted therapies and advancing precision medicine initiatives globally....1/28/2025 GMT https://www.marketsandmarkets.com/Market-Reports/gene-transfer-technologies-market-74062902.htmlThe global gene transfer technologies market, valued at US$3.63 billion in 2023, stood at US$3.73 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$5.93 billion by the end of the period. The increasing usage in vaccine development and applications in cancer immunotherapy; is one of the major factors driving the growth of the gene transfer technologies market....1/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/bioconjugation-market-232696083.htmlThe global bioconjugation market, valued at US$4.78 billion in 2023, stood at US$5.27 billion in 2024 and is projected to advance at a resilient CAGR of 15.6% from 2024 to 2029, culminating in a forecasted valuation of US$10.86 billion by the end of the period. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications....1/17/2025 GMT https://www.marketsandmarkets.com/Market-Reports/precision-medicine-market-215185595.htmlThe global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market....1/10/2025 GMT https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-cdmo-market-227700087.htmlThe global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field. ...1/9/2025 GMT https://www.marketsandmarkets.com/Market-Reports/single-use-assemblies-market-46226549.htmlThe global single-use assemblies market, valued at US$2.52 billion in 2023, stood at US$2.63 billion in 2024 and is projected to advance at a resilient CAGR of 13.2% from 2024 to 2029, culminating in a forecasted valuation of US$4.89 billion by the end of the period. The single-use assemblies market is experiencing significant growth with technological advancements....1/7/2025 GMT